Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 9/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.47 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.47 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.45 |
| ▸ | EMG1 | Q92979 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 3/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL9524883 | 1.00 | CYP19A1 (0.47) | CYP19A1CYP3A4CYP26A1CYP2C8CYP2D6 | |
| SCHEMBL9523819 | 0.81 | CYP19A1 (0.50) | CYP19A1CYP3A4CYP26A1CYP2C8CYP2D6 | |
| SCHEMBL9527065 | 0.80 | CYP17A1 (0.48) | CYP3A4CYP26A1KMT2ASMN1; SMN2CYP17A1 | |
| SCHEMBL9524756 | 0.79 | CYP19A1 (0.60) | CYP19A1CYP3A4CYP26A1CYP2C8CYP2D6 | |
| Oxalic Acid SCHEMBL27275153 | 0.74 | CYP19A1 (0.51) | CYP19A1CYP3A4CYP26A1CNR1KMT2A | |
| Oxalic Acid SCHEMBL9527036 | 0.74 | CYP19A1 (0.51) | CYP19A1CYP3A4CYP26A1CNR1KMT2A | |
| SCHEMBL14092717 | 0.73 | CYP19A1 (0.59) | CYP19A1CYP3A4CYP26A1CYP2C8CYP2D6 | |
| SCHEMBL3279238 | 0.72 | CYP19A1 (0.60) | CYP19A1CYP3A4CYP26A1CYP2C8CYP2D6 | |
| Oxalic Acid SCHEMBL9868434 | 0.71 | CYP19A1 (0.48) | CYP19A1CYP3A4CYP26A1CNR1KMT2A | |
| Oxalic Acid SCHEMBL27268074 | 0.71 | CYP19A1 (0.48) | CYP19A1CYP3A4CYP26A1CNR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0293978-B1 | (1H-AZOL-1-YLMETHYL)SUBSTITUTED BENZOTRIAZOLE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-09-15 | — | — | EP | disclosed |
| US-5039677-A | Estrogen inhibitor | JANSSEN PHARMACEUTICA N.V. (CA) | 1991-08-13 | — | — | US | disclosed |
| US-4943574-A | AROMATASE INHIBITORS, ESTROGEN DISORDERS | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-07-24 | — | — | US | disclosed |
| EP-0293978-A2 | (1H-azol-1-ylmethyl)substituted benzotriazole derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1988-12-07 | — | — | EP | disclosed |